Search in:

Advanced search

Expert Opinion on Drug Discovery Volume 3, 2008 - Issue 2

Submit an article Journal homepage

Views

CrossRef citations to date

Altmetric

Reviews

An update on using vitamin E in Alzheimer's disease

Anatol Kontush INSERM Unité 551, Pavillon Benjamin Delessert, Hôpital de la Pitié, 83 boulevard de l'Hôpital, 75651 Paris Cedex 13, France +33 1 42177976;+33 1 45828198; [email protected]

Svetlana Schekatolina State Academy of Refrigeration, Odessa, Ukraine

Pages 261-271 | Published online: 25 Jan 2008

Cite this article
https://doi.org/10.1517/17460441.3.2.261

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Bibliography

Vatassery GT. Vitamin E and other endogenous antioxidants in the central nervous system. Geriatrics 1998;53(Suppl 1):S25-7
PubMed Web of Science ®Google Scholar
Traber MG, Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med 2007;43(1):4-15
PubMed Web of Science ®Google Scholar
Azzi A. Molecular mechanism of alpha-tocopherol action. Free Radic Biol Med 2007;43(1):16-21
PubMed Web of Science ®Google Scholar
Yaari R, Corey-Bloom J. Alzheimer's disease. Semin Neurol 2007;27(1):32-41
PubMed Web of Science ®Google Scholar
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297(5580):353-6
PubMed Web of Science ®Google Scholar
Smith MA, Perry G. Free radical damage, iron, and Alzheimer's disease. J Neurol Sci 1995;134(Suppl):92-4
PubMed Web of Science ®Google Scholar
Mark RJ, Blanc EM, Mattson MP. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. Mol Neurobiol 1996;12(3):211-24
PubMed Web of Science ®Google Scholar
Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1997;23(1):134-47
PubMed Web of Science ®Google Scholar
Butterfield DA. Beta-amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem Res Toxicol 1997;10(5):495-506
PubMed Web of Science ®Google Scholar
Pratico D, Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am J Med 2000;109(7):577-85
PubMed Web of Science ®Google Scholar
Arlt S, Beisiegel U, Kontush A. Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease. Curr Opin Lipidol 2002;13(3):289-94
PubMed Web of Science ®Google Scholar
Pratico D, Virginia MYL, Trojanowski JQ, et al. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J 1998;12(15):1777-83
PubMed Web of Science ®Google Scholar
Lovell MA, Xie C, Markesbery WR. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 2001;22(2):187-94
PubMed Web of Science ®Google Scholar
Montine TJ, Beal MF, Cudkowicz ME, et al. Increased CSF F2-isoprostane concentration in probable AD. Neurology 1999;52(3):562-5
PubMed Web of Science ®Google Scholar
Quinn JF, Montine KS, Moore M, et al. Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. J Alzheimers Dis 2004;6(1):93-7
PubMed Web of Science ®Google Scholar
Ciabattoni G, Porreca E, Di Febbo C, et al. Determinants of platelet activation in Alzheimer's disease. Neurobiol Aging 2007;28(3):336-42
PubMed Web of Science ®Google Scholar
Montine TJ, Quinn JF, Milatovic D, et al. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Ann Neurol 2002;52(2):175-9
PubMed Web of Science ®Google Scholar
Pratico D, Zhukareva V, Yao Y, et al. 12/15-Lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress. Am J Pathol 2004;164(5):1655-62
PubMed Web of Science ®Google Scholar
Kontush A, Berndt C, Weber W, et al. Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic Biol Med 2001;30(1):119-28
PubMed Web of Science ®Google Scholar
Kontush A. Amyloid-beta: an antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease. Free Radic Biol Med 2001;31(9):1120-31
PubMed Web of Science ®Google Scholar
Zou K, Gong JS, Yanagisawa K, et al. A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J Neurosci 2002;22(12):4833-41
PubMed Web of Science ®Google Scholar
Hayashi T, Shishido N, Nakayama K, et al. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Radic Biol Med 2007;43(11):1552-9
PubMed Web of Science ®Google Scholar
Smith MA, Casadesus G, Joseph JA, et al. Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med 2002;33(9):1194-9
PubMed Web of Science ®Google Scholar
Atwood CS, Obrenovich ME, Liu T, et al. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res Brain Res Rev 2003;43(1):1-16
PubMed Web of Science ®Google Scholar
Kontush A. Apolipoprotein Abeta: black sheep in a good family. Brain Pathol 2004;14(4):433-47
PubMed Web of Science ®Google Scholar
Kontush A, Atwood CS. Amyloid-beta: phylogenesis of a chameleon. Brain Res Brain Res Rev 2004;46(1):118-20
PubMed Web of Science ®Google Scholar
Nunomura A, Perry G, Hirai K, et al. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Ann NY Acad Sci 1999;893362-4
Google Scholar
Pratico D, Uryu K, Leight S, et al. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001;21(12):4183-7
PubMed Web of Science ®Google Scholar
Butterfield DA. Amyloid beta-peptide (1 – 42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 2002;36(12):1307-13
PubMed Web of Science ®Google Scholar
Bassett CN, Neely MD, Sidell KR, et al. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo. Lipids 1999;34(12):1273-80
PubMed Web of Science ®Google Scholar
Schippling S, Kontush A, Arlt S, et al. Increased lipoprotein oxidation in Alzheimer's disease. Free Radic Biol Med 2000;28(3):351-60
PubMed Web of Science ®Google Scholar
Polidori MC, Mecocci P. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J Alzheimers Dis 2002;4(6):517-22
PubMed Web of Science ®Google Scholar
Galbusera C, Facheris M, Magni F, et al. Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients. Curr Alzheimer Res 2004;1(2):103-9
PubMed Web of Science ®Google Scholar
Tohgi H, Abe T, Nakanishi M, et al. Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia. Neurosci Lett 1994;174(1):73-6
PubMed Web of Science ®Google Scholar
Jimenez-Jimenez FJ, De Bustos F, Molina JA, et al. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease. J Neural Transm 1997;104(6-7):703-10
PubMed Web of Science ®Google Scholar
Pratico D, Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 2004;6(2):171-5
PubMed Web of Science ®Google Scholar
Williamson KS, Gabbita SP, Mou S, et al. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 2002;6(2):221-7
PubMed Web of Science ®Google Scholar
Quinn J, Suh J, Moore MM, et al. Antioxidants in Alzheimer's disease – vitamin C delivery to a demanding brain. J Alzheimers Dis 2003;5(4):309-13
PubMedGoogle Scholar
Kontush A, Mann U, Arlt S, et al. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. Free Radic Biol Med 2001;31(3):345-54
PubMed Web of Science ®Google Scholar
Skoumalova A, Rofina J, Schwippelova Z, et al. The role of free radicals in canine counterpart of senile dementia of the Alzheimer type. Exp Gerontol 2003;38(6):711-9
PubMed Web of Science ®Google Scholar
Metcalfe T, Bowen DM, Muller DP. Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls. Neurochem Res 1989;14(12):1209-12
PubMed Web of Science ®Google Scholar
Jeandel C, Nicolas MB, Dubois F, et al. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 1989;35(5-6):275-82
PubMed Web of Science ®Google Scholar
Zaman Z, Roche S, Fielden P, et al. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 1992;21(2):91-4
PubMed Web of Science ®Google Scholar
Sinclair AJ, Bayer AJ, Johnston J, et al. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. Int J Geriatr Psychiatry 1998;13(12):840-5
PubMed Web of Science ®Google Scholar
Foy CJ, Passmore AP, Vahidassr MD, et al. Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. QJM 1999;92(1):39-45
PubMed Web of Science ®Google Scholar
Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 2001;30(3):235-41
PubMed Web of Science ®Google Scholar
Mecocci P, Polidori MC, Cherubini A, et al. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol 2002;59(5):794-8
PubMed Web of Science ®Google Scholar
Rinaldi P, Polidori MC, Metastasio A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003;24(7):915-9
PubMed Web of Science ®Google Scholar
Ahlskog JE, Uitti RJ, Low PA, et al. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease. Mov Disord 1995;10(5):566-73
PubMed Web of Science ®Google Scholar
Kunicki S, Richardson J, Mehta PD, et al. The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid. Clin Biochem 1998;31(5):409-15
PubMed Web of Science ®Google Scholar
Riviere S, Birlouez-Aragon I, Nourhashemi F, et al. Low plasma vitamin C in Alzheimer patients despite an adequate diet. Int J Geriatr Psychiatry 1998;13(11):749-54
PubMed Web of Science ®Google Scholar
Fernandes MA, Proenca MT, Nogueira AJ, et al. Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients. Int J Mol Med 1999;4(2):179-86
PubMed Web of Science ®Google Scholar
Charlton KE, Rabinowitz TL, Geffen LN, et al. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J Nutr Health Aging 2004;8(2):99-107
PubMed Web of Science ®Google Scholar
Engelhart MJ, Ruitenberg A, Meijer J, et al. Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline. Dement Geriatr Cogn Disord 2005;19(2-3):134-9
PubMed Web of Science ®Google Scholar
Kontush A, Schekatolina S. Vitamin E in neurodegenerative disorders: Alzheimer's disease. Ann NY Acad Sci 2004;103:1249-62
Google Scholar
Bassett CN, Montine KS, Neely MD, et al. Cerebrospinal fluid lipoproteins in Alzheimer's disease. Microsc Res Tech 2000;50(4):282-6
PubMed Web of Science ®Google Scholar
Burns MP, Noble WJ, Olm V, et al. Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques. Brain Res Mol Brain Res 2003;110(1):119-25
PubMedGoogle Scholar
Arlt S, Finckh B, Beisiegel U, et al. Time-course of oxidation of lipids in human cerebrospinal fluid in vitro. Free Radic Res 2000;32(2):103-14
PubMed Web of Science ®Google Scholar
McIntosh LJ, Trush MA, Troncoso JC. Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes. Free Radic Biol Med 1997;23(2):183-90
PubMed Web of Science ®Google Scholar
Sung S, Yao Y, Uryu K, et al. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J 2004;18(2):323-5
PubMed Web of Science ®Google Scholar
Sayre LM, Perry G, Harris PL, et al. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 2000;74(1):270-9
PubMed Web of Science ®Google Scholar
Garcia-Alloza M, Dodwell SA, Meyer-Luehmann M, et al. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J Neuropathol Exp Neurol 2006;65(11):1082-9
PubMed Web of Science ®Google Scholar
Kim HS, Choi Y, Shin KY, et al. Swedish amyloid precursor protein mutation increases phosphorylation of eIF2alpha in vitro and in vivo. J Neurosci Res 2007;85(7):1528-37
PubMed Web of Science ®Google Scholar
Upston JM, Kritharides L, Stocker R. The role of vitamin E in atherosclerosis. Prog Lipid Res 2003;42(5):405-22
PubMed Web of Science ®Google Scholar
Kang JH, Cook N, Manson J, et al. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 2006;166(22):2462-8
PubMed Web of Science ®Google Scholar
Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352(23):2379-88
PubMed Web of Science ®Google Scholar
Onofrj M, Thomas A, Luciano AL, et al. Donepezil versus vitamin E in Alzheimer's disease. Part 2. Mild versus moderate-severe Alzheimer's disease. Clin Neuropharmacol 2002;25(4):207-15
PubMed Web of Science ®Google Scholar
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336(17):1216-22
PubMed Web of Science ®Google Scholar
Zandi PP, Anthony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004;61(1):82-8
PubMed Web of Science ®Google Scholar
Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002;287(24):3230-7
PubMed Web of Science ®Google Scholar
Morris MC, Beckett LA, Scherr PA, et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 1998;12(3):121-6
PubMed Web of Science ®Google Scholar
Morris MC, Evans DA, Tangney CC, et al. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 2005;81(2):508-14
PubMed Web of Science ®Google Scholar
Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002;287(24):3223-9
PubMed Web of Science ®Google Scholar
Wengreen HJ, Munger RG, Corcoran CD, et al. Antioxidant intake and cognitive function of elderly men and women: the Cache County Study. J Nutr Health Aging 2007;11(3):230-7
PubMed Web of Science ®Google Scholar
Luchsinger JA, Tang MX, Shea S, et al. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003;60(2):203-8
PubMed Web of Science ®Google Scholar
Gray SL, Anderson ML, Crane PK, et al. Antioxidant vitamin supplement use and risk of dementia or Alzheimer's disease in older adults. J Am Geriatr Soc 2007;2727
Google Scholar
Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000;54(6):1265-72
PubMed Web of Science ®Google Scholar
Shadlen MF, Larson EB, Yukawa M. The epidemiology of Alzheimer's disease and vascular dementia in Japanese and African-American populations: the search for etiological clues. Neurobiol Aging 2000;21(2):171-81
PubMed Web of Science ®Google Scholar
Laurin D, Masaki KH, Foley DJ, et al. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol 2004;159(10):959-67
PubMed Web of Science ®Google Scholar
Fillenbaum GG, Kuchibhatla MN, Hanlon JT, et al. Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E. Ann Pharmacother 2005;39(12):2009-14
PubMed Web of Science ®Google Scholar
Nishida Y, Yokota T, Takahashi T, et al. Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem Biophys Res Commun 2006;350(3):530-6
PubMed Web of Science ®Google Scholar
Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005;142(1):37-46
PubMed Web of Science ®Google Scholar
Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007;297(8):842-57
PubMed Web of Science ®Google Scholar
Vatassery GT, Bauer T, Dysken M. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am J Clin Nutr 1999;70(5):793-801
PubMed Web of Science ®Google Scholar
Berman K, Brodaty H. Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders. CNS Drugs 2004;18(12):807-25
PubMed Web of Science ®Google Scholar
Itoh N, Masuo Y, Yoshida Y, et al. gamma-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than alpha-tocopherol in mouse brain. Neurosci Lett 2006;403(1-2):136-40
PubMed Web of Science ®Google Scholar
Sen CK, Khanna S, Roy S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med 2007;28(5-6):692-728
PubMed Web of Science ®Google Scholar
Neuzil J, Weber C, Kontush A. The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease. Atherosclerosis 2001;157(2):257-83
PubMed Web of Science ®Google Scholar
Huang HY, Caballero B, Chang S, et al. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann Intern Med 2006;145(5):372-85
PubMed Web of Science ®Google Scholar
Swerdlow RH, Khan SM. A “mitochondrial cascade hypothesis” for sporadic Alzheimer's disease. Med Hypotheses 2004;63(1):8-20
PubMed Web of Science ®Google Scholar
Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007;47629-56
Google Scholar
Vina J, Lloret A, Orti R, et al. Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress. Mol Aspects Med 2004;25(1-2):117-23
PubMedGoogle Scholar
Roberts LJ II, Oates JA, Linton MF, et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med 2007;43(10):1388-93
PubMed Web of Science ®Google Scholar
Sutherland WH, Manning PJ, Walker RJ, et al. Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects. Obesity (Silver Spring) 2007;15(2):386-91
PubMed Web of Science ®Google Scholar
Devaraj S, Tang R, Adams-Huet B, et al. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 2007;86(5):1392-8
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

An update on using vitamin E in Alzheimer's disease

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

An update on using vitamin E in Alzheimer's disease

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date